A股異動 | 伊之密(300415.SZ)漲近6%創30個月新高價 前三季度淨利預增超21.35%
格隆匯10月13日丨伊之密(300415.SZ)午間收漲5.7%,4月底以來累計升幅超140%。現報15.92元創30個月新高價,成交1.65億元,總市值68.7億元。伊之密12日公告,預計前三季度實現淨利潤2.16億元–2.27億元,同比增長21.35%-27.57%。其中,三季度預計淨利潤1.15億元–1.26億元,同比增長129.37%-151.49%。第二、三季度,公司的經營情況快速改善,單季度的營業收入接連創下歷史新高,公司的盈利能力得到了快速的恢復。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.